Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00108550 · ClinicalTrials.gov registry record · Phase 2
Chronic Low Back Pain Research Project
A Phase 2 study of Chronic Low Back Pain, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 2
- Development phase
- 108
- Enrollment target
- 1
- Study location
NCT00108550: Completed Phase 2 study of Chronic Low Back Pain, sponsored by US Department of Veterans Affairs.
NCT00108550 is a Phase 2 study of Chronic Low Back Pain that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 108 participants, below the 591-participant average among 71 other Chronic Low Back Pain trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00108550, a Phase 2 study of Chronic Low Back Pain, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 108 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether gabapentin is efficacious as an analgesic for chronic low back pain.
Primary Outcome
Self-report measure of "current" pain intensity of chronic back pain. Participants rate pain on a 20 point scale as being greater or less intense relative to 12 adjectival descriptor word anchors (eg, greater or less than "faint," "moderate," "strong"). Scores range from 0 to 20 with higher scores indicating higher pain intensity. Prior to analysis an order-preserving mean-matching variance-stabilizing transformation was applied to this measure placing it on a continuous 0-1.5 scale. The single
Conditions Studied
Interventions
- DRUG gabapentin
- DRUG Inert placebo
Study Locations (1)
California
- VA San Diego Healthcare System, San Diego - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2004-10 |
| Est. Completion | 2009-09 |
| Phase | Phase 2 |
What the finished NCT00108550 record still lists
NCT00108550 is an interventional study that assigns participants to a tested intervention. The registered 108 participants enrollment target is mid-sized for trials with a published cap, below the 591-participant average among 71 other Chronic Low Back Pain trials with a reported enrollment target (82% lower).
The record links to 1 condition, with Chronic Low Back Pain appearing as the primary indexed condition, and to 2 interventions - of which gabapentin is the first listed.
NCT00108550 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00108550 about?
NCT00108550 is a clinical study titled "Chronic Low Back Pain Research Project". The purpose of this study is to determine whether gabapentin is efficacious as an analgesic for chronic low back pain.
What is the current status of trial NCT00108550?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 108 participants. The study started on 2004-10. Estimated completion is 2009-09.
What conditions does trial NCT00108550 study?
This clinical trial studies the following conditions: Chronic Low Back Pain.
What interventions are being tested in trial NCT00108550?
The interventions under investigation include: gabapentin (DRUG), Inert placebo (DRUG).
Who is sponsoring clinical trial NCT00108550?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00108550 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Low Back Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00108550's enrollment target sits among peer trials
108 32nd of 71 higher than 40 of 71 other Chronic Low Back Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Low Back Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketamine-assisted Integrative Treatment for Veterans With Chronic Low Back Pain and Comorbid Depression
RECRUITING · Phase 2
-
Modulation Effect of tACS on Chronic Low Back Pain
RECRUITING · Phase 2
-
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
RECRUITING · Phase 2
-
Project 1 Aim 2, Adaptations of the Brain in Chronic Pain With Opioid Exposure
ACTIVE NOT RECRUITING · Phase 2
-
Low-Dose Naltrexone and Acetaminophen Combination in the Treatment of Chronic Low Back Pain (ANODYNE-4)
COMPLETED · Phase 2
-
Treating Negative Affect in Low Back Pain Patients
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02703207 · 108 participants · NA
Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD
- NCT02744677 · 108 participants · NA
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction
- NCT02781883 · 108 participants · Phase 2
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML
- NCT03848663 · 108 participants · NA
Visual Remapping to Aid Reading With Field Loss
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia